从专利角度分析药物技术创新现状及研发思路——以低分子量肝素为例

Technical analysis of low molecule weight heparins patents and R&D suggestions

摘要: 本文对低分子量肝素的全球和中国的专利申请在技术上进行了分析，从专利技术的角度提出了关于低分子量肝素特别是依诺肝素、达肝素、那屈肝素的创新研发的建议。
- 低分子量肝素 /
- 专利 /
- 研发 /
- 依诺肝素 /
- 达肝素 /
- 那屈肝素
Abstract: An analysis of low molecule weight heparins(LMWH)patents throughout China and aroud the world is made. The suggestion, in terms of patent technical solution, is given to the R&D of LMWH, especially the enoxaparin, dalteprin and nadroparin.
- low molecule weight heparins(LMWH) /
- patent /
- R&D /
- enoxaparin /
- dalteprin /
- nadroparin

[1]	Lei ND.New drugs to sweeten,the pattern of the anticoagulant markets around the world changes highlighted(新型药物搅局,全球抗凝血药市场格局变化凸显)[J].China Prescr Drug(中国处方药),2013,11(7): 5-7.